AU2001234544A1 - Novel human protein kinases and protein kinase-like enzymes - Google Patents
Novel human protein kinases and protein kinase-like enzymesInfo
- Publication number
- AU2001234544A1 AU2001234544A1 AU2001234544A AU3454401A AU2001234544A1 AU 2001234544 A1 AU2001234544 A1 AU 2001234544A1 AU 2001234544 A AU2001234544 A AU 2001234544A AU 3454401 A AU3454401 A AU 3454401A AU 2001234544 A1 AU2001234544 A1 AU 2001234544A1
- Authority
- AU
- Australia
- Prior art keywords
- enzymes
- novel human
- protein
- protein kinase
- kinases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- 102000003839 Human Proteins Human genes 0.000 title 1
- 108090000144 Human Proteins Proteins 0.000 title 1
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17807800P | 2000-01-25 | 2000-01-25 | |
| US60178078 | 2000-01-25 | ||
| US17936400P | 2000-01-31 | 2000-01-31 | |
| US60179364 | 2000-01-31 | ||
| US18317300P | 2000-02-17 | 2000-02-17 | |
| US60183173 | 2000-02-17 | ||
| US19016200P | 2000-03-17 | 2000-03-17 | |
| US60190162 | 2000-03-17 | ||
| US19340400P | 2000-03-29 | 2000-03-29 | |
| US60193404 | 2000-03-29 | ||
| US24701300P | 2000-11-13 | 2000-11-13 | |
| US60247013 | 2000-11-13 | ||
| PCT/US2001/002337 WO2001055356A2 (en) | 2000-01-25 | 2001-01-25 | Human protein kinases and protein kinase-like enzymes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001234544A1 true AU2001234544A1 (en) | 2001-08-07 |
Family
ID=27558674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001234544A Abandoned AU2001234544A1 (en) | 2000-01-25 | 2001-01-25 | Novel human protein kinases and protein kinase-like enzymes |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1254214A2 (en) |
| JP (1) | JP2003520602A (en) |
| AU (1) | AU2001234544A1 (en) |
| CA (1) | CA2398430A1 (en) |
| WO (1) | WO2001055356A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2266195T3 (en) * | 2000-04-25 | 2007-03-01 | Bayer Healthcare Ag | NEW MOLECULES OF PROTEIN QUINASA 14911 AND USES OF THE SAME. |
| WO2002055685A2 (en) | 2000-12-11 | 2002-07-18 | Lexicon Genetics Incorporated | Novel human kinase and polynucleotides encoding the same |
| WO2002064762A2 (en) * | 2001-02-12 | 2002-08-22 | Bayer Aktiengesellschaft | Isolated polynucleotides encoding putative tyrosine kinase |
| US7001753B2 (en) | 2001-02-15 | 2006-02-21 | Millennium Pharmaceuticals, Inc. | 59079 and 12599, protein kinase family members and uses therefor |
| EP1402009A4 (en) * | 2001-05-24 | 2005-02-02 | Cephalon Inc | Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
| AU2002330672A1 (en) * | 2001-07-25 | 2003-02-17 | Genset S.A. | Gmg-1 polynucleotides and polypeptides and uses thereof |
| JP2005508168A (en) * | 2001-10-24 | 2005-03-31 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 69583 and 85924, novel human protein kinase family members and their use |
| US20030199462A1 (en) | 2002-04-23 | 2003-10-23 | Gabriel Nunez | Methods and compositions for regulating cellular signaling |
| AU2003240688A1 (en) * | 2002-05-24 | 2003-12-12 | Bayer Aktiengesellschaft | Regulation of human kinase |
| WO2005095637A1 (en) * | 2004-03-02 | 2005-10-13 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with mixed lineage kinase 4 beta (mlk4 beta) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO953680D0 (en) * | 1995-09-18 | 1995-09-18 | Hans Prydz | Cell cycle Enzymes |
| WO1999049062A1 (en) * | 1998-03-26 | 1999-09-30 | Gene Logic, Inc. | IDENTIFICATION OF A cDNA ASSOCIATED WITH ISCHEMIA IN HUMAN HEART TISSUE |
| ES2248997T3 (en) * | 1998-04-14 | 2006-03-16 | Sugen, Inc. | STE20-RELATED PROTEIN-KINASES. |
| AU4077099A (en) * | 1998-05-13 | 1999-11-29 | Incyte Pharmaceuticals, Inc. | Cell signaling proteins |
| AU4222300A (en) * | 1999-04-16 | 2000-11-02 | Scios Inc. | Mammalian protein with putative function in signal transduction |
-
2001
- 2001-01-25 EP EP01906658A patent/EP1254214A2/en not_active Withdrawn
- 2001-01-25 JP JP2001554387A patent/JP2003520602A/en not_active Withdrawn
- 2001-01-25 AU AU2001234544A patent/AU2001234544A1/en not_active Abandoned
- 2001-01-25 WO PCT/US2001/002337 patent/WO2001055356A2/en not_active Ceased
- 2001-01-25 CA CA002398430A patent/CA2398430A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003520602A (en) | 2003-07-08 |
| CA2398430A1 (en) | 2001-08-02 |
| WO2001055356A2 (en) | 2001-08-02 |
| EP1254214A2 (en) | 2002-11-06 |
| WO2001055356A3 (en) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1926001A (en) | Novel human protein kinases and protein kinase-like enzymes | |
| AU2001267475A1 (en) | Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof | |
| AU5173400A (en) | Protein kinases | |
| AUPQ801700A0 (en) | Enzyme and viral activation | |
| AU2001270260A1 (en) | 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors | |
| AU2001268525A1 (en) | Human kinases | |
| AU2001288612A1 (en) | Human kinases | |
| AU2001277959A1 (en) | Human kinases | |
| AU2002230788A1 (en) | Multiplexed protein expression and activity assay | |
| AU2001234544A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
| AU2292301A (en) | Human kinases | |
| AU5446900A (en) | Novel murine and human kinases | |
| AU4686299A (en) | Nek-related and bub1-related protein kinases | |
| AU2001255573A1 (en) | Human kinases | |
| AU2001279090A1 (en) | Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases | |
| AU2002227352A1 (en) | Human kinases | |
| AU1456899A (en) | Human protein kinase and kinase inhibitors | |
| AU2001284380A1 (en) | Therapeutic and cosmetic uses of heparanases | |
| AU2001268053A1 (en) | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof | |
| AU2002250041A1 (en) | Putative human enzymes | |
| AU2001237592A1 (en) | Enzymes and uses relating thereto | |
| HK1051703A (en) | Human protein kinases and protein kinase-like enzymes | |
| AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
| AU2001263287A1 (en) | Human protein kinase "13305" and uses therefor | |
| AU2001297794A1 (en) | Methods and compositions of human proteins and uses thereof. |